Medications for the Treatment of Opioid Use Disorder
public-health · Centers for Disease Control and Prevention · Rule · Published 2024-02-02 · Effective 2024-04-02 · 89 FR 7528
Document
Document number
2024-01693
Federal Register citation
89 FR 7528
CFR reference
42 CFR 8
Type
Rule
Action
Final rule.
Category
public-health
Sub-agency
Centers for Disease Control and Prevention
Publication date
2024-02-02
Effective date
2024-04-02
Abstract
This final rule modifies and updates certain provisions of regulations related to Opioid Treatment Program (OTP) accreditation, certification, and standards for the treatment of Opioid Use Disorder (OUD) with Medications for Opioid Use Disorder (MOUD) in OTPs. This includes making flexibilities put forth during the COVID-19 Public Health Emergency (PHE) permanent, as well as expanding access to care and evidence-based treatment for OUD. The final rule also removes all language and rules pertaining to the Drug Addiction and Treatment Act (DATA) Waiver from the regulations pursuant to the "Consolidated Appropriations Act, 2023".